337930 — Xexymix Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeSmall CapContrarian

Annual income statement for Xexymix, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	138,479	165,935	206,887	232,577	271,594
Cost of Revenue
Gross Profit	84,949	99,801	125,184	139,573	164,078
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	130,440	152,124	187,581	214,419	246,695
Operating Profit	8,039	13,811	19,306	18,158	24,899
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7,433	12,484	18,414	15,596	26,206
Provision for Income Taxes
Net Income After Taxes	6,898	12,783	14,288	12,744	20,929
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	6,994	7,721	10,061	11,235	20,665
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	6,994	7,721	10,061	11,235	20,665
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	275	441	487	414	711
Dividends per Share